Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Looking for a Better Creatinine
Meeusen, Jeffrey W. , Lieske, John C.

Clinical Chemistry | February 27, 2014 | Volume: 60 | Issue: 8 | Pages: 1036-1039

10.1373/clinchem.2013.220764 | PMID 24573605 Get It

Chronic subthreshold subdural cortical stimulation for the treatment of focal epilepsy originating from eloquent cortex
Child, Nicholas D., Stead, Matt, Nickels, Katherine , Wetjen, Nicholas M. , Lee, Kendall H. , Klassen, Bryan T. , Wirrell, Elaine , Nickels, Katherine C

Epilepsia | February 26, 2014 | Volume: 55 | Issue: 3 | Pages: No page available

10.1111/epi.12525 | PMID 24571166 Get It

SummaryMedically refractory epilepsy remains a major medical problem worldwide. Although some patients are eligible for surgical resection of seizure foci, a proportion of patients are ineligible for a variety of reasons. One such reason is that the foci reside in eloquent cortex of the brain and therefore resection would result in significant morbidity. This retrospective study reports our experience with a novel neurostimulation technique for the treatment of these patients. We identified three patients who were ineligible for surgical resection of the intracranially identified seizure focus because it resided in eloquent cortex, who underwent therapeutic trial of focal cortical stimulation delivered through the subdural monitoring grid. All three patients had a significant reduction in seizures, and two went on to permanent implantation, which resulted in long‐term reduction in seizure frequency. In conclusion, this small case report provides some evidence of proof of concept of the role of targeted continuous neocortical neurostimulation in the treatment of medically refractory focal epilepsy, and provides support for ongoing investigations into this treatment modality.A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.
Antibiofilm Activity of Manuka Honey in Combination with Antibiotics
Campeau, Michelle E. M., Patel, Robin

International Journal of Bacteriology | February 26, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-7

10.1155/2014/795281 | PMID 26904740 Get It

We assessed the in vitro activity of Manuka honey against biofilm bacteria in combination with antibiotics and visualized the effect of Manuka honey on bacterial biofilms using scanning electron microscopy. The fractional biofilm eradication concentration ( ∑ FBEC ) index for vancomycin plus Manuka honey against S. aureus IDRL-4284 biofilms was 0.34, indicating a synergistic interaction. The ∑ FBEC index for gentamicin plus Manuka honey against P. aeruginosa PAO1 biofilms was 0.78–0.82, indicating an additive interaction. Scanning electron microscopy of S. aureus IDRL-4284 and P. aeruginosa PAO1 biofilms exposed to Manuka honey and artificial honey containing the same sugar composition as Manuka honey showed that the former had more pronounced effects than the latter on both S. aureus and P. aeruginosa biofilms. Visualized effects included distorted cell morphologies for both bacteria and a decrease in P. aeruginosa extracellular matrix. In conclusion, Manuka honey has a synergistic interaction with vancomycin against S. aureus biofilms and an additive interaction with gentamicin against P. aeruginosa biofilms.
Absence of C9ORF72 expanded or intermediate repeats in autopsy‐confirmed Parkinson's disease
Nuytemans, Karen , Inchausti, Vanessa, Beecham, Gary W. , Wang, Liyong , Dickson, Dennis W. , Trojanowski, John Q. , Mash, Deborah C. , Frosch, Matthew P. , Montine, Thomas J. , Dawson, Ted M. , Martin, Eden R. , Scott, William K. , Vance, Jeffery M. , Lee, Virginia M.‐Y. , Foroud, Tatiana , Honig, Lawrence S. , Dickson, Dennis W

Movement Disorders | February 26, 2014 | Volume: 29 | Issue: 6 | Pages: 827-830

10.1002/mds.25838 | PMID 24573903 Get It

ABSTRACTBackgroundWe have reported that intermediate repeat lengths of the C9ORF72 repeat are a risk factor for Parkinson's disease (PD) in a clinically diagnosed data set. Because 10% to 25% of clinically diagnosed PD have different diagnoses upon autopsy, we hypothesized that this may reflect phenotypic heterogeneity or concomitant pathology of other neurodegenerative disorders.MethodsWe screened 488 autopsy‐confirmed PD cases for expansion haplotype tag rs3849942T. In 196 identified haplotype carriers, the C9ORF72 repeat was genotyped using the repeat‐primed polymerase chain reaction assay.ResultsNo larger (intermediate or expanded) repeats were found in these autopsy‐confirmed PD samples. This absence of larger repeats is significantly different from the frequency in clinically diagnosed datasets (P = 0.002).ConclusionsOur results suggest that expanded or intermediate C9ORF72 repeats in clinically diagnosed PD or parkinsonism might be an indication of heterogeneity in clinically diagnosed PD cases. Further studies are needed to elucidate the potential contribution of the C9ORF72 repeat to autopsy‐confirmed PD. © 2014 International Parkinson and Movement Disorder Society
Retrograde Ureteroscopy Via a Continent Urinary Diversion: Surgical Techniques and Common Pitfalls
Rivera, Marcelino , Krambeck, Amy E.

Journal of Endourology | February 26, 2014 | Volume: 28 | Issue: 7 | Pages: 763-766

10.1089/end.2014.0018 | PMID 24571679 Get It

The risk of asthma exacerbation after reducing inhaled corticosteroids: a systematic review and meta‐analysis of randomized controlled trials
Hagan, John B., Samant, Shefali, Volcheck, Gerald W., Li, J. T., Hagan, Christina R., Erwin, Patricia J., Rank, Matthew A.

Allergy | February 26, 2014 | Volume: 69 | Issue: 4 | Pages: 510-516

10.1111/all.12368 | PMID 24571355 Get It

AbstractBackgroundAsthma guidelines suggest reducing controller medications when asthma is stable.MethodsThe purpose of the study is to estimate the risk of asthma exacerbation in stable asthmatics who reduce inhaled corticosteroids (ICS) compared to those who maintain a stable ICS dose. We identified articles from a systematic review of English and non‐English articles using MEDLINE, EMBASE, Web of Science, and CENTRAL (inception to May 25, 2013). We included randomized controlled trials (RCTs) with a stable asthma run‐in period of 4 weeks or more, an intervention to reduce ICS, and a follow‐up period of at least 3 months.ResultsThe search strategy identified 2253 potential articles, of which 206 were reviewed at the full‐text level and 6 met criteria for inclusion. The relative risk of an asthma exacerbation in individuals who reduced ICS compared to those who maintained the same ICS dose was 1.25 (95% CI 0.96, 1.62; P = 0.10; I2 = 0%) in studies with a mean follow‐up of 22 weeks. Individuals who reduced ICS had a decreased% predicted FEV1 of 0.87% (95% CI −1.58%,3.33%; P = 0.49, I2 = 58%) and a decreased mean morning peak expiratory flow of 9.57 l/min (95% CI 1.25, 17.90; P = 0.02; I2 = 74%) compared to those individuals who maintained a stable ICS dose.ConclusionsAsthma exacerbations were statistically no more likely among individuals who reduced ICS compared to those who maintained their ICS dose, supporting current guidelines which recommend decreasing ICS by 50% after a period of asthma stability.
Reduced nocturnal ACTH-driven cortisol secretion during critical illness
Boonen, Eva , Meersseman, Philippe , Vervenne, Hilke, Meyfroidt, Geert , Güiza, Fabián , Wouters, Pieter, Veldhuis, Johannes D. , Berghe, Greet Van den

American Journal of Physiology-Endocrinology and Metabolism | February 26, 2014 | Volume: 306 | Issue: 8 | Pages: E883-E892

10.1152/ajpendo.00009.2014 | PMID 24569590 Get It

Recently, during critical illness, cortisol metabolism was found to be reduced. We hypothesize that such reduced cortisol breakdown may suppress pulsatile ACTH and cortisol secretion via feedback inhibition. To test this hypothesis, nocturnal ACTH and cortisol secretory profiles were constructed by deconvolution analysis from plasma concentration time series in 40 matched critically ill patients and eight healthy controls, excluding diseases or drugs that affect the hypothalamic-pituitary-adrenal axis. Blood was sampled every 10 min between 2100 and 0600 to quantify plasma concentrations of ACTH and (free) cortisol. Approximate entropy, an estimation of process irregularity, cross-approximate entropy, a measure of ACTH-cortisol asynchrony, and ACTH-cortisol dose-response relationships were calculated. Total and free plasma cortisol concentrations were higher at all times in patients than in controls (all P < 0.04). Pulsatile cortisol secretion was 54% lower in patients than in controls ( P = 0.005), explained by reduced cortisol burst mass ( P = 0.03), whereas cortisol pulse frequency ( P = 0.35) and nonpulsatile cortisol secretion ( P = 0.80) were unaltered. Pulsatile ACTH secretion was 31% lower in patients than in controls ( P = 0.03), again explained by a lower ACTH burst mass ( P = 0.02), whereas ACTH pulse frequency ( P = 0.50) and nonpulsatile ACTH secretion ( P = 0.80) were unchanged. ACTH-cortisol dose response estimates were similar in patients and controls. ACTH and cortisol approximate entropy were higher in patients ( P ≤ 0.03), as was ACTH-cortisol cross-approximate entropy ( P ≤ 0.001). We conclude that hypercortisolism during critical illness coincided with suppressed pulsatile ACTH and cortisol secretion and a normal ACTH-cortisol dose response. Increased irregularity and asynchrony of the ACTH and cortisol time series supported non-ACTH-dependent mechanisms driving hypercortisolism during critical illness.
In Vivo Durability and Safety of Rolled Acellular Dermis in a Submucosal Pocket in Pigs
O’Reilly, Ashley G., Powell, Benjamin D., García, Joaquín J. , Cofer, Shelagh A.

The Cleft Palate Craniofacial Journal | February 25, 2014 | Volume: 52 | Issue: 2 | Pages: 198-202

10.1597/13-158 | PMID 24568592 Get It

Objective This study explored posterior nasopharyngeal augmentation with an acellular dermal matrix sheeting. Design Evaluation of the persistence and safety of a submucosal implant of rolled acellular dermis over a 3-month period in a piglet model. Setting Institute Hills Facility, part of the Mayo Clinic Rochester health care facility. Participants Fifteen 5-week-old domestic piglets of unspecified gender. Interventions Twelve piglets were implanted at age 5 weeks with a rolled sheet of acellular dermal matrix (Strattice). Implants were inserted in a submucosal pocket in the soft palate. Three piglets underwent sham operations, with creation of submucosal pockets without implantation. After a 3-month observation period, the palates were harvested for evaluation. Results Grossly, persistence of bulk at the surgical site in 5 of the 12 implanted piglets was noted at 3 months. Histologically, no persistence of the dermal matrix could be observed. Incorporation and/or resorption of the dermal matrix occurred with minimal to no host inflammatory response. Conclusion This experiment demonstrated the safety of a rolled acellular dermal implant in a submucosal location in a pig model, without surgical complication, host inflammatory reaction, or rejection. Minimal, if any, bulk of the implant persisted in the implanted location after 3 months. Although acellular dermal matrix sheeting appears to be safe and well-tolerated, it does not offer a long-term treatment option for posterior pharyngeal augmentation.
Sequence analysis of EBV immediate-early gene BZLF1 and BRLF1 in lymphomas
Yang, Ying , Jia, Yuping , Wang, Yun , Sun, Zhifu , Wang, Xiaofeng , Luo, Bing , Sun, Zhifu

Journal of Medical Virology | February 25, 2014 | Volume: 86 | Issue: 10 | Pages: 1788-1795

10.1002/jmv.23911 | PMID 24615673 Get It

Pulmonary Hyalinizing Granuloma Associated with Idiopathic Thrombocytopenic Purpura
Coleman, Christopher, Nassar, Aziza , McComb, Barbara L., McComb, Barbara, Nassar, Aziza

Journal of Clinical Imaging Science | February 25, 2014 | Volume: 4 | Issue: No issue available | Pages: 8

10.4103/2156-7514.127835 | PMID 24744965 Get It

Pulmonary hyalinizing granuloma (PHG) is a rare, benign lung disease of unknown etiology. It manifests as discrete, rounded nodules within the lung parenchyma. A 39-year-old woman presented for investigation after pulmonary nodules were found incidentally. Chest computed tomography showed multiple, discrete, non-enhancing pulmonary nodules bilaterally. Positron emission tomography (PET) was negative. Biopsy demonstrated a non-specific lymphoplasmacytic infiltrate. Open resection yielded two nodules consistent with hyalinizing granulomas. The differential for multiple pulmonary nodules is broad. PET scan can help rule out metastatic disease, although some cancers are not hypermetabolic on PET. Furthermore, some non-malignant conditions, including hyalinizing granuloma, can show increased activity on PET. PHG should be included in the differential of multiple pulmonary nodules, especially if nodule stability can be demonstrated and/or needle biopsies are non-diagnostic. Associated immune-mediated conditions, such as idiopathic thrombocytopenic purpura (ITP) in our patient, may also favor HG. In this case report we find an association between PHG and ITP.